Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.750
-0.090 (-3.17%)
At close: Mar 12, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Mar 12, 2026, 7:46 PM EDT
Gain Therapeutics Employees
As of December 31, 2024, Gain Therapeutics had 25 total employees, including 23 full-time and 2 part-time employees. The number of employees decreased by 7 or -21.88% compared to the previous year.
Employees
25
Change (1Y)
-7
Growth (1Y)
-21.88%
Revenue / Employee
n/a
Profits / Employee
-$775,670
Market Cap
105.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 25 | -7 | -21.88% | 23 | 2 |
| Dec 31, 2023 | 32 | 1 | 3.23% | 29 | 3 |
| Dec 31, 2022 | 31 | 2 | 6.90% | 28 | 3 |
| Dec 31, 2021 | 29 | 15 | 107.14% | 25 | 4 |
| Dec 31, 2020 | 14 | 10 | 250.00% | 11 | 3 |
| Sep 30, 2020 | 12 | 8 | 200.00% | 9 | 3 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Agenus | 316 |
| Codexis | 188 |
| Gossamer Bio | 145 |
| Inovio Pharmaceuticals | 134 |
| Biomea Fusion | 42 |
| Oncolytics Biotech | 28 |
| Cognition Therapeutics | 28 |
| Q32 Bio | 26 |
GANX News
- 16 hours ago - Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update - GlobeNewsWire
- 21 days ago - Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week - GlobeNewsWire
- 2 months ago - Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 - GlobeNewsWire
- 3 months ago - Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease - GlobeNewsWire
- 3 months ago - Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson's Disease - GlobeNewsWire
- 4 months ago - Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 - GlobeNewsWire
- 4 months ago - Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update - GlobeNewsWire